SAN FRANCISCO--(BUSINESS WIRE)--4D Molecular Therapeutics (4DMT), a leader in next-generation gene therapy vector discovery and product development, today announced a collaboration and license ...

The VDL is currently restructuring and not providing services at this time. For all request of viral vectors, please visit the Gene Vector Core Website or send an email to [email protected]. Since ...

Technology products are not static. They evolve in response to shifts in the market or changing customer expectations. The most successful companies prioritize product development to maintain a ...

Joint Solution to Drive Adoption of "Shift-Left" Software Development Methodologies with the Integration of Synopsys' Electronics Digital Twin Capabilities and Vector's Software Factory SUNNYVALE, ...

The small business environment today is very dynamic and competitive, and new product development is a crucial process if you want to survive. For small enterprises to withstand competition from ...

Effective process development for viral vector-based medicines is paramount for optimized process efficiency, robustness, scalability, and product quality. Well-designed processes streamline ...